Search Login Register

Plague (Bubonic Plague) Summary

Description: An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.

Also Known As: Bubonic Plague; Pneumonic Plague; Plague, Bubonic; Black Death; Black Plague Show All >>

Networked: 1485 relevant articles (123 outcomes, 120 trials/studies) for this Disease

Key Drugs and Agents for Plague

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antigens : 27 outcomes 19 studies in 280 results : IBA
  2. Vaccines : 13 outcomes 15 studies in 132 results : IBA
  3. Antibodies : 9 outcomes 7 studies in 104 results : IBA
  4. Anti-Bacterial Agents (Antibiotics) : 9 outcomes 1 study in 62 results : IBA
  5. Plague Vaccine : 8 outcomes 2 studies in 23 results : IBA
  6. Ciprofloxacin (Cipro) : 7 outcomes 2 studies in 20 results : FDA 60 Generic
  7. Streptomycin (Streptomycin Sulfate) : 6 outcomes 2 studies in 55 results : FDA 7
  8. Proteins (Proteins, Gene) : 5 outcomes 1 study in 62 results : IBA
  9. Rifampin (Rifampicin) : 4 outcomes 3 studies in 16 results : FDA 13 Generic
  10. Gentamicins (Gentamicin) : 4 outcomes 3 studies in 16 results : FDA 63 Generic
Show All >>

Diseases Related to Plague

  1. Infection
  2. Plague (Bubonic Plague)
  3. Anthrax
  4. Tularemia
  5. Brucellosis (Malta Fever)
Show All >>

Key Therapies for Plague

Efficacy Chart >>
  1. Oral Administration : 2 outcomes in 4 results
  2. Drug Therapy (Chemotherapy) : 1 outcome in 13 results
  3. Transplants (Transplant) : 1 outcome in 9 results
  4. Microspheres (Microsphere) : 1 outcome in 7 results
  5. Transcutaneous Electric Nerve Stimulation (TENS) : 1 outcome in 5 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.